Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Federico, Rea ^a   Adolfo, Favaretto ^b   Giuseppe, Marulli ^a   Lorenzo, Spaggiari ^c   Martino, DePas Tommaso ^c   Anna, Ceribelli ^d   Adriano, Paccagnella ^e   Gino, Crivellari ^e   Francesca, Russo ^f   Matteo, Ceccarelli ^f   Gbenga, Kazeem ^g   Paolo, Marchi ^f   Francesco, Facciolo ^d  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e OSPEDALE DELL'ANGELO   (Italy)

^f Erl Wood Manor ^*  (Italy)

^g Lilly UK   (United Kingdom)

Author keywords

Chemotherapy; Pemetrexed; Pleural mesothelioma; Radiation; Surgery

Indexed keywords

CISPLATIN; CYANOCOBALAMIN; DEXAMETHASONE; FOLIC ACID; PEMETREXED; ANTINEOPLASTIC AGENT; GLUTAMIC ACID DERIVATIVE; GUANINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURGERY; CARDIOPULMONARY INSUFFICIENCY; CONTROLLED STUDY; DEATH; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; OPEN STUDY; OVERALL SURVIVAL; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PLEURA MESOTHELIOMA; RADIATION BEAM; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; ADJUVANT THERAPY; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MESOTHELIOMA; MIDDLE AGED; MORTALITY; PLEURAL NEOPLASMS; PROCEDURES; RADIOTHERAPY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; GLUTAMATES; GUANINE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MESOTHELIOMA; MIDDLE AGED; NEOADJUVANT THERAPY; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY;

EID: 84872200263     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-22     Document Type: Article

References (13)

1. Robinson BW, Lake RA. Advances in malignant mesothelioma. New Engl J Med 2005, 353:1591-603. 10.1056/NEJMra050152, 16221782.
2. Belli C, Fennell D, Giovannini M, Gaudino G, Mutti L. Malignant pleural mesothelioma: current treatments and emerging drugs. Expert Opin Emerg Drugs 2009, 14:423-437. 10.1517/14728210903074563, 19552609.
3. Weder W, Opitz I, Stahel R. Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2009, 21:172-176. 10.1053/j.semtcvs.2009.07.004, 19822290.
4. Zucali PA, De Vincenzo F, Simonelli M, Santoro A. Future developments in the management of malignant pleural mesothelioma. Expert Rev Anticancer Ther 2009, 9:453-467. 10.1586/era.09.2, 19374599.
5. Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011, 12:763-772. 10.1016/S1470-2045(11)70149-8, 3148430, 21723781.
6. Singhal S, Kaiser LR. Malignant mesothelioma: options for management. Surg Clin North Am 2002, 82:797-831. 10.1016/S0039-6109(02)00033-6, 12472131.
7. Marangolo M, Vertogen B. Pemetrexed and malignant pleural mesothelioma. Ann Oncol 2006, 17(Suppl 5):v103-105.
8. Vogelzang NJ, Rusthoven J, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003, 21:2636-2644. 10.1200/JCO.2003.11.136, 12860938.
9. McAleer MF, Tsao AS, Liao Z. Radiotherapy in malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2009, 75:326-337. 10.1016/j.ijrobp.2009.06.037, 19735859.
10. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:3007-3013. 10.1200/JCO.2008.20.3943, 19364962.
11. Weder W, Stahel RA, Bernhard J, et al. for the Swiss Group for Clinical Cancer Research Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007, 18:1196-1202. 10.1093/annonc/mdm093, 17429100, for the Swiss Group for Clinical Cancer Research.
12. Van Schil PE, Baas P, Gaafar R, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010, 36:1362-1369. 10.1183/09031936.00039510, 20525721.
13. Weder W, Stahel RA, Baas P, et al. The MARS feasibility trial: conclusions not supported by data. Lancet Oncol 2011, 12(12):1093-1094.